Skip to content

Effect of Gudardraka and Gudanagara in Bronchial Asthma

Pharmaceutical standardization of Gudardraka and Gudanagara and their comparative efficacy in Tamaka Shwasa ( Bronchial Asthma)-a double blind randomized clinical trial

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050978
Enrollment
60
Registered
2023-03-22
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

None listed

Sponsors

Director
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients presenting with minimum 3-4 sign and symptoms of Tamaka Shwasa i.e.Ten ruddho ghurghurukak(wheezing sound), Ateev vegam ch shwasa pranpeedakam(breathlessness or paroxysm of breathlessness), Na cha api nidra labhte shayanah(awakening at night) Ati vegvata cha kaaste( cough) as per classical text 2)Mild persistent cases of Asthma as per GINA guidelines 2022

Exclusion criteria

Exclusion criteria: 1) Moderate persistent, severe persistent to severe asthma 2) Dyspnoea resulting from other disease like left ventricular failure, COPD, chronic bronchitis, emphysema, upper respiratory tract obstruction, bronchiectasis, ILD etc 3) Patients on regular steroidal therapy, inhalers or bronchodilators 4) Patients having pneumonia, tuberculosis, lung cancer, lung abscess and other such complicated condition 5)Patient having diabetes, hypertension, acute and chronic renal failure etc conditions in which urination is markedly diminished or excessive will be excluded 6) HIV positive patients 7) Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
1)Improvement in classical sign and symptoms of bronchial asthma i.e ten ruddho ghurghurukam(wheezing sound), ateev teevra vegam ch shwasa pranpeedkam(breathlessness or paroxysm of breathlessness), na cha api nidra labhte shayanah(awakening at night), ati vegavata cha kaaste(cough) 2)Decrease in frequency, duration and severity of attacks 3)Change in PEFRTimepoint: 28 days

Secondary

MeasureTime frame
Change in asthma control questionnaire scoreTimepoint: 28 days

Countries

India

Contacts

Public ContactDr Pradeep Kumar Prajapati

All India Institute of Ayurveda

prajapati.pradeep1@gmail.com9818575845

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026